Pathogen- and Host-Directed Antileishmanial Effects Mediated by Polyhexanide (PHMB)

Leishmaniasis

(2015) Esther Von Stebut   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Identification of multiple cellular uptake pathways of polystyrene nanoparticles and factors affecting the uptake: Relevance for drug delivery systems

(2014) Rebuma Firdessa et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis

(2014) Esther Moreno et al.   Expert Opinion on Drug Delivery

The role of IL-4 and IL-13 in cutaneous Leishmaniasis

(2014) Ramona Hurdayal et al.   IMMUNOLOGY LETTERS

Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy

(2014) Luís Novo et al.   JOURNAL OF CONTROLLED RELEASE

Non-viral vectors for gene-based therapy

(2014) Hao Yin et al.   NATURE REVIEWS GENETICS

The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis

(2014) Mary-Anne Hartley et al.   TRENDS IN PARASITOLOGY

Determinants of disease phenotype in trypanosomatid parasites

(2014) Laura-Isobel McCall et al.   TRENDS IN PARASITOLOGY

Cathepsin B in Antigen-Presenting Cells Controls Mediators of the Th1 Immune Response during Leishmania major Infection

(2014) Iris J. Gonzalez-Leal et al.   PLoS Neglected Tropical Diseases

Rapid Healing of Cutaneous Leishmaniasis by High-Frequency Electrocauterization and Hydrogel Wound Care with or without DAC N-055: A Randomized Controlled Phase IIa Trial in Kabul

(2014) Ahmad Fawad Jebran et al.   PLoS Neglected Tropical Diseases

Drug repurposing and human parasitic protozoan diseases

(2014) Katherine T. Andrews et al.   International Journal for Parasitology-Drugs and Drug Resistance

A Novel Leishmania major Amastigote Assay in 96-Well Format for Rapid Drug Screening and Its Use for Discovery and Evaluation of a New Class of Leishmanicidal Quinolinium Salts

(2013) Gerhard Bringmann et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis

(2013) Sushmita Das et al.   BRITISH JOURNAL OF PHARMACOLOGY

Interaction of polyhexamethylene biguanide hydrochloride (PHMB) with phosphatidylcholine containing o/w emulsion and consequences for microbicidal efficacy and cytotoxicity

(2013) Gerald Müller et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Editorial Commentary: Local Treatments for Cutaneous Leishmaniasis

(2013) M. S. Bailey   CLINICAL INFECTIOUS DISEASES

Travelers With Cutaneous Leishmaniasis Cured Without Systemic Therapy

(2013) G. Morizot et al.   CLINICAL INFECTIOUS DISEASES

Therapeutic Options for Old World Cutaneous Leishmaniasis and New World Cutaneous and Mucocutaneous Leishmaniasis

(2013) Begoña Monge-Maillo et al.   DRUGS

Cationic Antimicrobial Polymers and Their Assemblies

(2013) Ana Carmona-Ribeiro et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Immunomodulatory effects of antileishmanial drugs

(2013) M. Ghosh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

UNC93B1 and Nucleic Acid-sensing Toll-like Receptors Mediate Host Resistance to Infection withLeishmania major

(2013) Bruno Luiz Fonseca Schamber-Reis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis

(2013) Arash Momeni et al.   JOURNAL OF LIPOSOME RESEARCH

Inflammasome-derived IL-1β production induces nitric oxide–mediated resistance to Leishmania

(2013) Djalma S Lima-Junior et al.   NATURE MEDICINE

Topical Paromomycin with or without Gentamicin for Cutaneous Leishmaniasis

(2013) Afif Ben Salah et al.   NEW ENGLAND JOURNAL OF MEDICINE

Raman Microspectroscopy Analysis in the Treatment of Acanthamoeba Keratitis

(2013) Giulia Rusciano et al.   PLoS One

Modes of action of three disinfectant active substances: A review

(2013) Stephen Wessels et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Cationic polymers and their therapeutic potential

(2012) Sangram Keshari Samal et al.   CHEMICAL SOCIETY REVIEWS

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

(2012) Guilherme Carneiro et al.   Expert Opinion on Drug Delivery

Leishmaniasis: an update of current pharmacotherapy

(2012) Shyam Sundar et al.   EXPERT OPINION ON PHARMACOTHERAPY

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

CpG Oligodeoxynucleotide 2006 and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis

(2011) Suman Gupta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides

(2011) Masaki Yamamoto et al.   BIOMATERIALS

Topical delivery andin vivoantileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis

(2010) Guilherme Carneiro et al.   JOURNAL OF LIPOSOME RESEARCH

Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis

(2010) Faraaz B. Chekeni et al.   NATURE

Polihexanide: A Safe and Highly Effective Biocide

(2010) K. Kaehn   SKIN PHARMACOLOGY AND PHYSIOLOGY

Accelerated wound healing mediated by activation of Toll-like receptor 9

(2010) Takashi Sato et al.   WOUND REPAIR AND REGENERATION

Structure−Activity Relationship and Studies on the Molecular Mechanism of LeishmanicidalN,C-Coupled Arylisoquinolinium Salts

(2009) Alicia Ponte-Sucre et al.   JOURNAL OF MEDICINAL CHEMISTRY